Eastman Chemical (NYSE: EMN) reported Q4 EPS of $0.89, $0.36 worse than the analyst estimate of $1.25. Revenue for the quarter came in at $2.37 billion versus the consensus estimate of $2.43 billion.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.